Last reviewed · How we verify
BREMEN eye drops
BREMEN eye drops is a topical ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.
BREMEN eye drops is a topical ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface. Used for Dry eye disease / Keratoconjunctivitis sicca.
At a glance
| Generic name | BREMEN eye drops |
|---|---|
| Sponsor | EMS |
| Drug class | Artificial tear / Lubricant |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
BREMEN is a preservative-free artificial tear solution intended for topical ocular use. It works by providing lubrication to the cornea and conjunctiva, reducing friction and irritation associated with dry eye syndrome. The formulation aims to stabilize the tear film and protect the ocular surface from further damage.
Approved indications
- Dry eye disease / Keratoconjunctivitis sicca
Common side effects
- Ocular irritation
- Transient blurred vision
- Eye discomfort
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BREMEN eye drops CI brief — competitive landscape report
- BREMEN eye drops updates RSS · CI watch RSS
- EMS portfolio CI